Health resource utilization associated with switching to risperidone long-acting injection
β Scribed by C. L. Young; D. M. Taylor
- Book ID
- 109341086
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 146 KB
- Volume
- 114
- Category
- Article
- ISSN
- 0001-690X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## Objective An international, nonβrandomised study evaluated efficacy and safety of risperidone longβacting injectable (RLAI) compared to previous treatment. To investigate generisability of the European data set to the UK subset safety and switching data are reported here. ## Method
## Abstract ## Objective To investigate changes in cognitive function and clinical features following a switch from oral atypical antipsychotics (AAPs) to longβacting injectable risperidone (LAIR) in patients with schizophrenia. ## Methods Thirtyβsix patients with schizophrenia treated with oral